BBA Clinical is an open access biomedical journal dedicated to human research. It brings together clinical and biochemical human studies, providing a new venue for researchers using observational studies and clinical trials to understand the molecular and biochemical processes involved in human disease.
All articles in BBA Clinical should describe, in part or entirely, studies using human patient samples or human cohorts. Manuscripts should emphasize the implications that biochemical mechanisms have for the observed clinical findings, and focus on describing how the data contribute to understanding and treatment of the clinical condition. Highly descriptive and method-development submissions may be declined without review.
Clinical areas of particular interest include aging, cancer, cardiovascular-, metabolic-, neurological-, and immunological-based diseases; the interactions that may occur among these diseases and conditions; and studies that examine early or pre-symptomatic states. Cross-sectional and prospective studies from well-established cohorts, and studies involving imaging methodologies, are particularly encouraged.
Invited reviews and editorials, focused on cutting-edge aspects of clinical research, will appear on a regular basis to complement regular research articles. Unsolicited review articles will be considered only in exceptional cases, and should be preceded by a letter of enquiry from the author, outlining the proposed review and compelling reasons why the subject is timely and important.BBA Clinical is the clinical complement to BBA Molecular Basis of Disease, which focuses on the molecular and biochemical basis of such conditions in pre-clinical studies, such as cell culture and animal models.
Executive Editor: Jeffrey Keller, PhD
- Imprint: ELSEVIER
- ISSN: 2214-6474